Literature DB >> 15005953

Health state utilities in gastroesophageal reflux disease patients with heartburn: a study in Germany and Sweden.

Bernt Kartman1, Gudrun Gatz, Magnus Johannesson.   

Abstract

The objectives of this study were to assess health state utilities in patients with gastroesophageal reflux disease with heartburn and to analyze if severity and annual frequency of heartburn can predict utilities. A total of 1011 patients in Germany and Sweden participated in telephone interviews, where utilities were assessed using the rating scale (RS), EQ-5D, time trade-off (TTO) and standard gamble (SG) instruments. The average RS, EQ-5D, TTO, and SG utilities were 0.69, 0.70, 0.88, and 0.89, respectively. Linear regression analyses showed that the EQ-5D and RS utilities were negatively and significantly related to the severity and frequency of heartburn. The EQ-5D and RS results indicate that patients with heartburn assign their health states substantial disutility and that it is feasible to estimate regression equations to predict utilities from heartburn-specific variables. In the TTO and SG analyses, the impact of heartburn was in the expected direction but smaller and in general not significant.

Entities:  

Mesh:

Year:  2004        PMID: 15005953     DOI: 10.1177/027298X03261563

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  7 in total

1.  Effects of structured follow-up and of more effective acid inhibitory treatment in the management of GORD patients in a Swedish primary-care setting: a randomized, open-label study.

Authors:  Rickard Ekesbo; Svante Sjöstedt; Heléne Sörngård
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

2.  The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.

Authors:  Dan Comay; Viviane Adam; Ediardo B da Silveira; Wendy Kennedy; Serge Mayrand; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

3.  Utilities and disutilities for attributes of injectable treatments for type 2 diabetes.

Authors:  Kristina S Boye; Louis S Matza; Kimberly N Walter; Kate Van Brunt; Andrew C Palsgrove; Aodan Tynan
Journal:  Eur J Health Econ       Date:  2010-03-12

4.  Economic analysis of on-demand maintenance therapy with proton pump inhibitors in patients with non-erosive reflux disease.

Authors:  Dyfrig A Hughes; Keith Bodger; Peter Bytzer; Dirk de Herdt; Dominique Dubois
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Utilities and disutilities for type 2 diabetes treatment-related attributes.

Authors:  Louis S Matza; Kristina S Boye; Nicole Yurgin; Jessica Brewster-Jordan; Sally Mannix; Jodi M Shorr; Beth L Barber
Journal:  Qual Life Res       Date:  2007-07-19       Impact factor: 4.147

6.  Impact of PPIs on patient focused symptomatology in GERD.

Authors:  Abr Thomson
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

7.  Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France.

Authors:  Stanislas Bruley des Varannes; Helena Granstedt Löfman; Maria Karlsson; Peter Wahlqvist; Magnus Ruth; Mary Lou Furstnau; Nicolas Despiégel; Nils-Olov Stålhammar
Journal:  BMC Gastroenterol       Date:  2013-02-28       Impact factor: 3.067

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.